Conmed (CNMD) Tops Q3 EPS by 6c, Misses on Revenue; offers FY24 Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $49.27 -2.26%
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Weighted average common shares Basic: 27.82M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q3 EPS of $1.05, $0.06 better than the analyst estimate of $0.99. Revenue for the quarter came in at $316.7 million versus the consensus estimate of $318.15 million.
GUIDANCE:
Conmed sees FY2024 EPS of $4.00-$4.05, versus the consensus of $3.99. Conmed sees FY2024 revenue of $1.3-1.31 billion, versus the consensus of $1.31 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Fed policy stance keeps Treasury yields high, says Citadel Securities
- Guggenheim Reiterates Buy Rating on EyePoint Inc. (EYPT)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
